Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have earned an average rating of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $30.83.
Several analysts have recently commented on OPCH shares. Barrington Research lowered their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research report on Thursday. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and set a $27.00 target price on the stock. in a report on Monday. JMP Securities boosted their price target on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a report on Monday, September 30th. Truist Financial decreased their price objective on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th.
Read Our Latest Stock Analysis on Option Care Health
Option Care Health Price Performance
NASDAQ OPCH traded down $1.62 during trading hours on Monday, reaching $22.49. The company's stock had a trading volume of 3,593,011 shares, compared to its average volume of 1,483,424. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73. The company's 50-day moving average is $30.31 and its two-hundred day moving average is $29.85. Option Care Health has a fifty-two week low of $22.46 and a fifty-two week high of $34.63. The stock has a market cap of $3.83 billion, a PE ratio of 18.90, a PEG ratio of 1.74 and a beta of 1.32.
Insider Buying and Selling at Option Care Health
In related news, CFO Michael H. Shapiro sold 23,217 shares of the firm's stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the company's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the business. Norden Group LLC increased its position in shares of Option Care Health by 42.3% in the first quarter. Norden Group LLC now owns 15,138 shares of the company's stock worth $508,000 after acquiring an additional 4,501 shares in the last quarter. Diversify Advisory Services LLC purchased a new position in Option Care Health in the first quarter valued at about $307,000. FORA Capital LLC lifted its stake in shares of Option Care Health by 109.7% during the first quarter. FORA Capital LLC now owns 23,011 shares of the company's stock worth $772,000 after purchasing an additional 12,037 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Option Care Health in the first quarter worth about $464,000. Finally, Texas Permanent School Fund Corp grew its stake in shares of Option Care Health by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 155,023 shares of the company's stock valued at $5,199,000 after buying an additional 2,008 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Option Care Health Company Profile
(
Get Free ReportOption Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.